Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd

Bullboard Posts

Post by laroplexon Dec 02, 2016 9:27am

155 Views

Post# 25545401

Stifano is supporting LBL on the Open market!!

Latest 10 SEDI filings (by transaction date) for LBL within the last 6 months

	?
Amended Filing

					As of 11:59pm ET December 1st, 2016
Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	Volume or Value	Price
Dec 1/16	Dec 1/16	Stifano, Mario	Direct Ownership	Common Shares	10 - Acquisition in the public market	5,000	$0.245